CAMP Continuation Study/Phase 2

加州大学圣地亚哥分校(UCSD)和圣迭戈Kaiser Permanente(KP)圣地亚哥分校自1991年签订合同并授予合同以来，一直作为8个临床中心之一参与儿童哮喘管理计划(CAMP)试验和CAMPCS。对于CAMP，我们的网站随机选择了122名5-12岁患有轻中度哮喘的儿童，其中40%来自少数民族。 我们的研究设施装备齐全，有助于执行CAMPCS/2的所有方面。研究的科学部分是华盛顿大学申请中提供的CAMPCS/2多中心提案的一部分。我们加州大学圣迭戈分校/KP临床中心愿意参与这项申请所要求的额外后续行动，如上所述，我们的记录支持我们这样做的能力。

The University of California at San Diego (UCSD) and Kaiser Permanente (KP) San Diego have participated as one of the 8 Clinical Centers in the Childhood Asthma Management Program (CAMP) Trial and CAMP Continuation Study (CAMPCS) since contract inception and award in 1991. For CAMP, our site randomized the required 122 children 5-12.years of age with mild to moderate asthma of which 40% were from ethnic minorities. Our research facilities are well equipped and conducive to perform all aspects of CAMPCS/2. The scientific portion of the study is part of the CAMPCS/2 multicenter proposal provided in the Washington University application. We at the UCSD/KP Clinical Center are willing to participate in the additional follow-up requested by this application and our track record as noted above is supportive of our ability to do so.